For CD8+ T cells, the DCM group presented a significant increase in the proportion of CD8+ T cells (38.74 ± 15.19% vs. 24.48 ± 8.34%, p < 0.001), which was consistent with the prediction by the ssGSEA algorithm. The gene discussed is CD8A; the disease is familial dilated cardiomyopathy.